Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IXEKIZUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 16,569 adverse event reports in the FDA FAERS database where IXEKIZUMAB was used for Psoriasis.

Most Reported Side Effects for IXEKIZUMAB

Side Effect Reports % Deaths Hosp.
Injection site pain 3,799 11.3% 0 64
Psoriasis 2,818 8.4% 9 162
Drug ineffective 2,759 8.2% 6 113
Injection site erythema 2,144 6.4% 1 27
Injection site reaction 1,701 5.1% 1 42
Injection site swelling 1,615 4.8% 1 27
Incorrect dose administered 1,032 3.1% 1 2
Covid-19 861 2.6% 16 67
Product dose omission issue 832 2.5% 1 15
Therapy interrupted 796 2.4% 0 46
Injection site pruritus 772 2.3% 0 10
Rash 717 2.1% 1 78
Arthralgia 714 2.1% 1 83
Diarrhoea 667 2.0% 3 67
Pain 656 2.0% 1 77

Other Indications for IXEKIZUMAB

Product used for unknown indication (10,759) Psoriatic arthropathy (5,798) Ankylosing spondylitis (795) Rheumatoid arthritis (298) Axial spondyloarthritis (129) Pustular psoriasis (81) Guttate psoriasis (57) Arthritis (47) Polyarthritis (44) Palmoplantar pustulosis (40)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628) HUMIRA (6,346)

Related Pages

IXEKIZUMAB Full Profile All Psoriasis Drugs IXEKIZUMAB Demographics IXEKIZUMAB Timeline